Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients

The coronavirus disease 2019 (COVID-19) emerged around December 2019 and have become a global epidemic disease currently. Specific antibodies against SAS-COV-2 could be detected in COVID-19 patients’ serum or plasma, but the clinical values of these antibodies as well as the effects of clinical drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Liwen, Shang, Yuqi, Liu, Xi, Li, Xinghua, Chen, Gongqi, Liang, Siping, Zou, Zhengyu, Ding, Tao, Hong, Zhongsi, Wu, Minhao, Xia, Jinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220093/
https://www.ncbi.nlm.nih.gov/pubmed/34177879
http://dx.doi.org/10.3389/fimmu.2021.580989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220093/
https://www.ncbi.nlm.nih.gov/pubmed/34177879
http://dx.doi.org/10.3389/fimmu.2021.580989

Ejemplares similares